Morgan Stanley’s BIO-key International BKYI Stock Holding History

Morgan Stanley’s Portfolio BKYI Stock Details BKYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-200	Closed	-$1.06K	–	8432
2026 Q1	$1.06K	Buy	+200	New	+$1.24K	﹤0.01%	7427
2023 Q1	–	Hold	0	–	-$6	–	7718
2022 Q4	–	Hold	0	–	–	–	7823
2022 Q2	–	Hold	0	–	–	–	7810
2022 Q1	–	Hold	0	–	–	–	7964
2021 Q4	–	Hold	0	–	–	–	7979
2021 Q3	–	Hold	0	–	–	–	7934

Morgan Stanley's BKYI Position: Q2 2026 in Review

Morgan Stanley sold out of BIO-key International (BKYI) in Q2 2026, closing a stake of 200 shares — an estimated $1.06K sold.

Morgan Stanley first reported a position in BKYI in Q1 2026 and held it in 1 quarter. The position peaked at $1.06K in Q1 2026. 0 funds tracked by Wall St. Rank hold BKYI as of Q2 2026.

Morgan Stanley reported no remaining BIO-key International position as of Q2 2026 after selling out during the quarter.
Morgan Stanley sold 200 BIO-key International shares in Q2 2026, an estimated $1.06K.
Morgan Stanley first reported a position in BIO-key International in Q1 2026 and held it in 1 quarter.
Morgan Stanley's BIO-key International position peaked at $1.06K in Q1 2026.
0 funds tracked by Wall St. Rank held BIO-key International as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.